DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock

Abstract Aims The DanGer Shock (DGS) trial demonstrated that the routine use of a microaxial flow pump (mAFP) with standard care to treat STEMI‐related cardiogenic shock (STEMI‐CS) led to a lower risk of all‐cause death at 180 days than standard care alone. We investigated the impact of patient elig...

Descripció completa

Dades bibliogràfiques

Autors principals:	Norman Mangner, Johannes Mierke, Dominik Baron, Felix J. Woitek, Stephan Haussig, Thomas Nowack, Ephraim B. Winzer, Julia Fischer, Robert Höllriegel, Stefanie Jellinghaus, Axel Linke
Format:	Artigo
Idioma:	Inglês
Publicat:	Oxford University Press 2025-08-01
Col·lecció:	ESC Heart Failure
Matèries:	Cardiogenic shock ST‐elevation myocardial infarction Mechanical circulatory support Microaxial flow pump DanGer Shock
Accés en línia:	https://doi.org/10.1002/ehf2.15269
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!